The Immunotherapy Candidate TNFSF4 May Help the Induction of a Promising Immunological Response in Breast Carcinomas

Investigators identified the oncogenic features of TNFSF4 in breast carcinoma. TNFSF4 was revealed to be closely related to treatment that induced antitumor immunity and to interact with multiple immune effector molecules and T cell signatures